Truist Financial Maintains Molina Healthcare(MOH.US) With Buy Rating, Announces Target Price $400
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Neurocrine (NBIX) and Viking Therapeutics (VKTX)
Bernstein Maintains Molina Healthcare(MOH.US) With Buy Rating, Maintains Target Price $414
A Quick Look at Today's Ratings for Molina Healthcare(MOH.US), With a Forecast Between $309 to $362
Molina Health Is Maintained at Equal-Weight by Barclays
Molina Healthcare Analyst Ratings
Correction: Barclays Adjusts Molina Healthcare Price Target to $362 From $339
Barlcays Adjusts Molina Healthcare Price Target to $362 From $339
Research Alert: Moh Reports Q1 Results, Beating Expectations On Sales
Molina Healthcare (MOH) Gets a Buy From TD Cowen
Molina Healthcare Analyst Ratings
Bernstein Initiates Molina Healthcare(MOH.US) With Buy Rating, Announces Target Price $414
Bernstein Initiates Molina Healthcare at Outperform With $414 Price Target
Molina Health Cut to Neutral From Outperform by Baird
Baird Downgrades Molina Healthcare(MOH.US) to Hold Rating, Raises Target Price to $375
Truist Financial Maintains Molina Healthcare(MOH.US) With Buy Rating, Raises Target Price to $400
Truist Securities Maintains Buy on Molina Healthcare, Raises Price Target to $400
Barclays Remains a Hold on Molina Healthcare (MOH)
Mizuho Securities Maintains Molina Healthcare(MOH.US) With Buy Rating, Raises Target Price to $400
Molina Healthcare Analyst Ratings